Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Halo Pharmaceutical Canada Inc

02 3Halo Pharmaceutical, Inc.

03 12Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2025-05-30

Noramco Halo Pharmaceutical

02

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2023-02-17

Noramco Halo Pharmaceutical

03

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2023-02-17

Noramco Halo Pharmaceutical

04

FDA Audited

USA

Halo Pharmaceutical

City : Mirabel

State :

Country/Area : Canada

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2023-02-17

Noramco Halo Pharmaceutical

05

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-12-20

Noramco Halo Pharmaceutical

06

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-12-20

Noramco Halo Pharmaceutical

07

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2018-05-30

Noramco Halo Pharmaceutical

08

FDA Audited

USA

Halo Pharmaceutical

City : Mirabel

State :

Country/Area : Canada

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-09-15

Noramco Halo Pharmaceutical

09

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-08-24

Noramco Halo Pharmaceutical

10

FDA Audited

USA

Halo Pharmaceutical

City : Whippany

State : New Jersey

Country/Area : U.S.A

Zip : 7981

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-03-20

Noramco Halo Pharmaceutical